Form 8-K - Current report:
SEC Accession No. 0001104659-22-127101
Filing Date
2022-12-15
Accepted
2022-12-15 06:00:35
Documents
45
Period of Report
2022-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232540d2_8k.htm   iXBRL 8-K 47489
2 EXHIBIT 99.1 tm2232540d2_ex99-1.htm EX-99.1 20632
3 EXHIBIT 99.2 tm2232540d2_ex99-2.htm EX-99.2 39960
7 GRAPHIC tm2232540d2_ex99-1img01.jpg GRAPHIC 3088
8 GRAPHIC tm2232540d2_ex99-2img001.jpg GRAPHIC 405787
9 GRAPHIC tm2232540d2_ex99-2img002.jpg GRAPHIC 415233
10 GRAPHIC tm2232540d2_ex99-2img003.jpg GRAPHIC 293663
11 GRAPHIC tm2232540d2_ex99-2img004.jpg GRAPHIC 418849
12 GRAPHIC tm2232540d2_ex99-2img005.jpg GRAPHIC 317427
13 GRAPHIC tm2232540d2_ex99-2img006.jpg GRAPHIC 220937
14 GRAPHIC tm2232540d2_ex99-2img007.jpg GRAPHIC 219043
15 GRAPHIC tm2232540d2_ex99-2img008.jpg GRAPHIC 217246
16 GRAPHIC tm2232540d2_ex99-2img009.jpg GRAPHIC 184134
17 GRAPHIC tm2232540d2_ex99-2img010.jpg GRAPHIC 138326
18 GRAPHIC tm2232540d2_ex99-2img011.jpg GRAPHIC 196147
19 GRAPHIC tm2232540d2_ex99-2img012.jpg GRAPHIC 304637
20 GRAPHIC tm2232540d2_ex99-2img013.jpg GRAPHIC 208568
21 GRAPHIC tm2232540d2_ex99-2img014.jpg GRAPHIC 219602
22 GRAPHIC tm2232540d2_ex99-2img015.jpg GRAPHIC 186198
23 GRAPHIC tm2232540d2_ex99-2img016.jpg GRAPHIC 275783
24 GRAPHIC tm2232540d2_ex99-2img017.jpg GRAPHIC 264408
25 GRAPHIC tm2232540d2_ex99-2img018.jpg GRAPHIC 269862
26 GRAPHIC tm2232540d2_ex99-2img019.jpg GRAPHIC 120999
27 GRAPHIC tm2232540d2_ex99-2img020.jpg GRAPHIC 272147
28 GRAPHIC tm2232540d2_ex99-2img021.jpg GRAPHIC 245773
29 GRAPHIC tm2232540d2_ex99-2img022.jpg GRAPHIC 255206
30 GRAPHIC tm2232540d2_ex99-2img023.jpg GRAPHIC 290406
31 GRAPHIC tm2232540d2_ex99-2img024.jpg GRAPHIC 139669
32 GRAPHIC tm2232540d2_ex99-2img025.jpg GRAPHIC 270701
33 GRAPHIC tm2232540d2_ex99-2img026.jpg GRAPHIC 373650
34 GRAPHIC tm2232540d2_ex99-2img027.jpg GRAPHIC 335236
35 GRAPHIC tm2232540d2_ex99-2img028.jpg GRAPHIC 264458
36 GRAPHIC tm2232540d2_ex99-2img029.jpg GRAPHIC 323869
37 GRAPHIC tm2232540d2_ex99-2img030.jpg GRAPHIC 251016
  Complete submission text file 0001104659-22-127101.txt   11132369

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxs-20221215.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20221215_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20221215_pre.xml EX-101.PRE 22597
39 EXTRACTED XBRL INSTANCE DOCUMENT tm2232540d2_8k_htm.xml XML 3603
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 221463570
SIC: 2834 Pharmaceutical Preparations